rat LRG ELISA
- Regulatory Status
- RUO
- Kit size
- 12x8
- Method
- ELISA
- Incubation time
- 1x90min, 2x30min
- Standard range
- 6.25 - 400 ng/mL
- Specimen / Volumes
- 100 µL serum, EDTA-plasma, urine, cell culture supernatant
- Substrate / isotope
- TMB 450 nm
Leucine rich alpha2-glycoprotein (LRG) is one of leucine-rich repeat family proteins. LRG has been shown to be involved in protein-protein interaction, signal transduction, cell adhesion and cell development. Recently, it was shown that serum levels of LRG were significantly elevated in Rheumatoid arthritis (RA) patients compared to healthy controls and decreased after anti-TNF therapy. Other publications indicate that LRG levels in cerebrospinal fluid in iNPH (idiopathic Normal Pressure Hydrocephalus) patients are remarkably elevated compared with controls and it may be possible to differentiate iNPH patients from others showing similar symptoms like Alzheimer’s disease.
Additionally it could be used to follow therapeutic success of shunting of iNPH patients.
This product is an ELISA kit for measuring of Rat LRG.
Separate control set available on request
Distributed by IBL International
Our Product Families
Our comprehensive immunoassay portfolio includes a number of specialty diagnostic immunoassays for endocrinology, immunology and autoimmunity, as well as for diagnosis of multiple infectious diseases. We are pioneers and market leaders in saliva diagnostics, with over 40 years of experience supplying a broad portfolio of luminescence- and ELISA-based tests, including our highly acclaimed HMGB1 and MuSK-Ab ELISAs.
And as experts in laboratory automation, we can support our customers with the protocols for open ELISA platforms, such as the Freedom EVOlyzer or Thunderbolt®.
All products are only available for sale to laboratory professionals and may not be available in all countries. Availability and regulatory status may vary across regions depending on local country-specific registration. Please always read and follow the instructions for use.
All of our assays have been designed and manufactured to meet the highest global regulatory requirements and quality standards. Tecan is certified under ISO 9001:2015, ISO 13485:2016 and is audited by a notified body according to Medical Device Single Audit Program (MDSAP).
This is who we are.
As part of the Tecan Group, we have a leading market position in diagnostics and research, with over 40 years of experience in the development, manufacture and supply of enzyme-, radiolabel- and luminescence-based immunoassays.
Our range of high-quality immunoassays is supported by a diverse portfolio of automated solutions, making us the perfect partner for you and your customers.
Happy to help.
At Tecan, we are driven to improve people’s lives and health.